Those few melanoma patients whose tumor was characterized with high BMAL1 mRNA expression had prolonged survival, possibly as a result of reduced key DNA-repair enzyme expressions, increased mutational/neoantigen load, and strong intratumoral T-cell infiltration and activation [144]. The gene discussed is BMAL1; the disease is neoplasm.